Autologous stem cell transplant is feasible in very elderly patients with lymphoma and limited comorbidity

American Journal of Hematology

Volumn 87, Issue 4, 2012, Pages 433-435

  Elstrom, Rebecca L ^a   Martin, Peter ^a   Rua, Sandra Hurtado ^a   Shore, Tsiporah B ^a   Furman, Richard R ^a   Ruan, Jia ^a   Pearse, Roger N ^a   Coleman, Morton ^a   Mark, Tomer ^a   Leonard, John P ^a   Gergis, Usama ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; MELPHALAN; MITOXANTRONE; THIOTEPA;

AGED; AUTOLOGOUS STEM CELL TRANSPLANTATION; CLINICAL ARTICLE; COMORBIDITY; DISEASE SEVERITY; ELDERLY CARE; FEASIBILITY STUDY; FEMALE; GRAFT INFECTION; HEART ARRHYTHMIA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; LETTER; MALE; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SURVIVAL TIME; TREATMENT RESPONSE; VERY ELDERLY; WHOLE BODY RADIATION;

AGE FACTORS; AGED; AGED, 80 AND OVER; COMORBIDITY; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; FEASIBILITY STUDIES; FEMALE; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHOMA, NON-HODGKIN; MALE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SALVAGE THERAPY; SEVERITY OF ILLNESS INDEX; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 84863399439     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23108     Document Type: Letter

References (14)

1. Jantunen E, Itala M, Juvonen E, et al. Autologous stem cell transplantation in elderly (>60 years) patients with non-Hodgkin's lymphoma: A nation-wide analysis. Bone Marrow Transplant 2006; 37: 367-372.
2. Wildes TM, Augustin KM, Sempen D, et al. Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma. Biol Blood Marrow Transplant 2008; 14: 840-846.
3. Hosing C, Saliba RM, Okoroji G-J, et al. High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of age. Ann Oncol 2008; 19: 1166-1171.
4. Jantunen E, Canals C, Atta M, et al. Autologous stem cell transplantation in patients with mantle cell lymphoma beyond 65 years of age:a study from the European Group for Blood and Marrow Transplantation (EBMT). Ann Oncol 2012; 23: 166-171.
5. Buadi FK, Micallef IN, Ansell SM, et al. Autologous heamatopietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphoma. Bone Marrow Transplant 2006; 37: 1017-1022.
6. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40: 373-383.
7. Sorror ML, Maris MB, Storb R, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: A new tool for risk assessment before allogeneic HCT. Blood 2005; 106: 2912-2919.
8. Jantunen E, Mahlamaki E, Nousiainen T. Feasibility and toxicity of high-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly patients (=60 years) with non-Hodgkin's lymphoma: Comparison with patients <60 years treated within the same protocol. Bone Marrow Transplant 2000; 26: 737-741.
9. Kusnierz-Glaz CR, Schlegel PG, Wong RM, et al. Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignancies. J Clin Oncol 1997; 15: 18-25.
10. Mileshkin LR, Seymour JF, Wolf MM, et al. Cardiovascular toxicity is increased, but manageable, during high-dose chemotherapy and autologous peripheral blood stem cell transplantation for patients aged 60 years and older. Leuk Lymphoma 2005; 46: 1575-1579.
11. Andorsky DJ, Cohen M, Naeim A, Pinter-Brown L. Outcomes of auto-SCT for lymphoma in subjects aged 70 years and over. Bone Marrow Transplant 2011; 46: 1219-1225.
12. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
13. Brookmeyer R, Crowley J. A confidence interval for the median survival time. Biometrics 1982; 38: 29-41.
14. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2011. Available at: